# L-Carnitine as an Osmo-metabolic Agent for Peritoneal Dialysis

> **NCT00851838** · PHASE2 · COMPLETED · sponsor: **Iperboreal Pharma Srl** · enrollment: 5 (actual)

## Conditions studied

- End-Stage Renal Disease

## Interventions

- **DRUG:** L-Carnitine

## Key facts

- **NCT ID:** NCT00851838
- **Lead sponsor:** Iperboreal Pharma Srl
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2012-10
- **Final completion:** 2012-12
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2019-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00851838

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00851838, "L-Carnitine as an Osmo-metabolic Agent for Peritoneal Dialysis". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00851838. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*